跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
安博诺 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Irbesartan and Hydrochlorothiazide Tablets
Approved
化学药品
Irbesartan and Hydrochlorothiazide Tablets
SANOFI WINTHROP INDUSTRIE
🇨🇳 National Medical Products Administration
Approval Date
Jan 12, 2023
Approval ID
1z32SMsWByq
Company
SANOFI WINTHROP INDUSTRIE
Type
化学药品
Approval Details
Approval Id
1z32SMsWByq
Approval Number
国药准字HJ20140195
Generic Name
厄贝沙坦氢氯噻嗪片
Generic Name En
Irbesartan and Hydrochlorothiazide Tablets
Trade Name
安博诺
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含厄贝沙坦150mg，氢氯噻嗪12.5mg
Reg Date
2023-01-12
Expired Date
2028-01-11
Company Name
SANOFI WINTHROP INDUSTRIE
Production Company Name
SANOFI WINTHROP INDUSTRIE
Company Detail Path
/organization/sanofi-winthrop-industrie
Production Company Detail Path
/organization/sanofi-winthrop-industrie
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 12, 2023
Approval ID
1z32SMsWByq
Type
化学药品
Back to NMPA Approvals
